Forte Biosciences (FBRX) Misses Q3 EPS by 2c

Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• United Community Banks sells equipment finance unit for $1.9 billion